Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Very promising clinical trial results achieved with leukemia treatment

Dec. 7, 1999

In vivo antiangiogenic activity described for FMPA

Dec. 7, 1999

ImClone and Merck KGaA initiate first international phase III trial center of C225

Dec. 6, 1999

Maret initiates clinical development of MARstem for chemotherapy-induced neutropenia

Dec. 3, 1999

Foscan NDA accepted for review

Dec. 3, 1999

Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo

Dec. 1, 1999

Eukarion awarded SBIR grant to develop treatment for radiation damage

Dec. 1, 1999

MMP inhibitor NF-681 targets renal cell carcinoma

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

Efficacy of FXR-targeting therapy validated by Symphar-Ilex team

Dec. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...